Your browser doesn't support javascript.
loading
Pituitary Apoplexy: Comorbidities, Management and Outcomes. A Spanish Observational Multicenter Study.
Biagetti, Betina; Cordero Asanza, Esteban; Pérez-López, Carlos; Araujo-Castro, Marta; Camara, Rosa; Guerrero-Pérez, Fernando; Vicente, Almudena; Lamas, Cristina; Serra, Guillermo; Echarri, Ana Irigaray; Ollero, M Dolores; González Molero, Inmaculada; Villar-Taibo, Rocío; Moure Rodríguez, María Dolores; García-Feijoo, Pablo; Berrocal, Víctor Rodríguez; Sánchez Ramirez, María Noelia; Hurtado, Alba Gutiérrez; Capristan-Díaz, Vanessa; Simó-Servat, Andreu; Gallach, Marta; Safont Perez, Eva; González Rosa, Victoria; Civantos, Soralla; Asensio-Wandosell, Diego; Martinez-Saez, Elena; Menéndez Torre, Edelmiro; Aulinas, Anna; Iglesias, Pedro; Diez, Juan J; Bernabéu, Ignacio; Álvarez-Escolá, Cristina; Puig-Domingo, Manel.
Afiliação
  • Biagetti B; Endocrinology & Nutrition Department. Hospital Universitario Vall de Hebrón. CIBERER U747 (ISCIII), ENDO-ERN, Universitat Autónoma de Bracelona, Barcelona, Spain.
  • Cordero Asanza E; Neurosurgery Department, Hospital Universitario Vall de Hebrón. Universitat Autónoma de Barcelona, Barcelona, Spain.
  • Pérez-López C; Department of Neurosurgery, Hospital Universitario La Paz. Madrid, Madrid, Spain.
  • Araujo-Castro M; Department of Endocrinology and Nutrition. Hospital Universitario Ramón y Cajal. Madrid, Spain.
  • Camara R; Endocrinology & Nutrition Service, La Fe University Hospital, Valencia, Spain.
  • Guerrero-Pérez F; Department of Endocrinology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Vicente A; Endocrinology & Nutrition Department. Hospital Universitario de Toledo. Toledo, Spain.
  • Lamas C; Endocrinology & Nutrition Department. Hospital Universitario De Albacete, Albacete, Spain.
  • Serra G; Department of Endocrinology, Son Espases University Hospital, Palma de Mallorca, Spain.
  • Echarri AI; Department of Endocrinology, University Hospital of Navarre, Pamplona, Spain.
  • Ollero MD; Department of Endocrinology, University Hospital of Navarre, Pamplona, Spain.
  • González Molero I; Endocrinology & Nutrition Department. Hospital Regional Universitario de Málaga. IBIMA Plataforma BIONAND Málaga, Spain.
  • Villar-Taibo R; Endocrinology & Nutrition Department. Hospital Universitario de Santiago de Compostela. Madrid, Spain.
  • Moure Rodríguez MD; Endocrinology & Nutrition Department. Hospital Universitario de Cruces. Bilbao, Spain.
  • García-Feijoo P; Department of Neurosurgery, Hospital Universitario La Paz. Madrid, Madrid, Spain.
  • Berrocal VR; Department of Neurosurgery. Hospital Universitario Ramón y Cajal. Madrid, Spain.
  • Sánchez Ramirez MN; Department of Endocrinology and Nutrition. Hospital Universitario Ramón y Cajal. Madrid, Spain.
  • Hurtado AG; Endocrinology & Nutrition Department. Hospital Universitario Central de Asturias. Instituto de Investigación del Principado de Asturias (ISPA). Asturias, Spain.
  • Capristan-Díaz V; Department of Endocrinology, Hospital Universitario Puerta de Hierro Majadahonda, Instituto de Investigación Sanitaria Puerta de Hierro Segovia de Arana, Majadahonda, Spain. Department of Medicine, Universidad Autónoma de Madrid, Spain.
  • Simó-Servat A; Department of Endocrinology and Nutrition, Mutua de Terrassa University Hospital, Terrassa, Spain.
  • Gallach M; Endocrinology & Nutrition Department. Hospital Universitario De Albacete, Albacete, Spain.
  • Safont Perez E; Endocrinology & Nutrition Department. Hospital de la Santa Creu i Sant Pau, IR-SANTPAU, CIBERER-U747 (ISCIII), ENDO-ERN, Barcelona, Spain.
  • González Rosa V; Endocrinology & Nutrition Department. Hospital Hospital Universitario Insular de Gran Canaria, Spain.
  • Civantos S; Endocrinology & Nutrition Department. Hospital Universitario Fuenlabrada. Madrid, Spain.
  • Asensio-Wandosell D; Endocrinology & Nutrition Service, Germans Trias Hospital and Research Institute, Badalona, Centro de Investigación Biomédica en Red de Enfermedades Raras U747, Autonomous University of Barcelona, Barcelona, Spain.
  • Martinez-Saez E; Pathology Department, Hospital Universitario Vall de Hebrón. Universitat Autónoma de Barcelona, Barcelona, Spain.
  • Menéndez Torre E; Endocrinology & Nutrition Department. Hospital Universitario Central de Asturias. Instituto de Investigación del Principado de Asturias (ISPA). Asturias, Spain.
  • Aulinas A; Endocrinology & Nutrition Department. Hospital de la Santa Creu i Sant Pau, IR-SANTPAU, CIBERER-U747 (ISCIII), ENDO-ERN, Barcelona, Spain.
  • Iglesias P; Department of Endocrinology, Hospital Universitario Puerta de Hierro Majadahonda, Instituto de Investigación Sanitaria Puerta de Hierro Segovia de Arana, Majadahonda, Spain. Department of Medicine, Universidad Autónoma de Madrid, Spain.
  • Diez JJ; Department of Endocrinology, Hospital Universitario Puerta de Hierro Majadahonda, Instituto de Investigación Sanitaria Puerta de Hierro Segovia de Arana, Majadahonda, Spain. Department of Medicine, Universidad Autónoma de Madrid, Spain.
  • Bernabéu I; Endocrinology & Nutrition Department. Hospital Universitario de Santiago de Compostela. Madrid, Spain.
  • Álvarez-Escolá C; Endocrinology Department, Hospital Universitario La Paz, Madrid, Spain.
  • Puig-Domingo M; Endocrinology & Nutrition Service, Germans Trias Hospital and Research Institute, Badalona, Centro de Investigación Biomédica en Red de Enfermedades Raras U747, Autonomous University of Barcelona, Barcelona, Spain.
Article em En | MEDLINE | ID: mdl-39298667
ABSTRACT

BACKGROUND:

Pituitary apoplexy (PA) is the paradigm of endocrine and neurosurgical emergency.

OBJECTIVE:

To evaluate the comorbidities, risk factors, clinical presentation, pituitary apoplexy score (PAS) and the outcomes of surgical vs. conservative management of PA in Spain.

METHODS:

Spanish multicenter, observational study of 301 patients with acute PA. Statistical analyses compared risk factors, clinical presentation and outcomes between the surgical and conservative treatment groups, adjusting for potential confounders. The prevalence of cardiovascular risk factors in patients with pituitary apoplexy was compared with the Spanish population and with patients with non-functioning pituitary adenomas.

RESULTS:

Median age was 59.3 years, 201 (66.8%) were men and non-functioning adenomas (77.9%) were the most common tumor type. The prevalence of diabetes (20.3% vs 13.9%, p<0.01), hypertension (48.8% vs 33.4%, p<0.01) and dyslipidemia (44.2% vs 23.3%, p<0.01), exceeded the Spanish age-adjusted population prevalence. Overall, 209 (69.4%) underwent surgery and 92 (30.6%) received conservative treatment. Surgical patients had larger tumors (26.2 vs 21.0 mm, p<0.01), chiasmal compression more frequently (77.2% vs 53.4%, p<0.01) and higher values of PAS. In the follow-up, while there were no statistically significant differences in anterior pituitary hormonal deficits between treatments, permanent vasopressin deficiency was more frequent after surgery (14.8% vs 3.3%, p<0.01).

CONCLUSION:

There is a high burden of cardiovascular risk factors among patients with PA suggesting that metabolic factors may play a potential role in the development of PA. This underscores the need for comprehensive management of these conditions in addition to treating the apoplexy itself in this population. Surgical management has a relevant place in PA approach mainly in patients with higher PAS. However, it leads permanent vasopressin deficit more frequently than conservative approach.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article